Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-31

Clinical Trial Update: Hepatocyte Transplantation as a Life Support Bridge [NA]

View source ↗

Summary

Clinical trial NCT00282542 evaluating hepatocyte transplantation as a life-support bridge for fulminant hepatic failure has been withdrawn, sponsored by Virgini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Fulminant Liver Failure | NA | Status: WITHDRAWN